Mirae Asset Global Investments Co. Ltd. Boosts Position in CVS Health Corporation $CVS

Mirae Asset Global Investments Co. Ltd. increased its holdings in CVS Health Corporation (NYSE:CVS) by 11.2% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 225,116 shares of the pharmacy operator’s stock after acquiring an additional 22,653 shares during the quarter. Mirae Asset Global Investments Co. Ltd.’s holdings in CVS Health were worth $16,971,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also added to or reduced their stakes in CVS. SOA Wealth Advisors LLC. grew its holdings in shares of CVS Health by 36.9% during the 3rd quarter. SOA Wealth Advisors LLC. now owns 486 shares of the pharmacy operator’s stock worth $37,000 after acquiring an additional 131 shares during the period. Symmetry Partners LLC boosted its position in shares of CVS Health by 2.5% during the third quarter. Symmetry Partners LLC now owns 5,826 shares of the pharmacy operator’s stock valued at $439,000 after purchasing an additional 141 shares in the last quarter. Harbor Capital Advisors Inc. grew its stake in CVS Health by 72.1% in the third quarter. Harbor Capital Advisors Inc. now owns 339 shares of the pharmacy operator’s stock worth $26,000 after purchasing an additional 142 shares during the period. HF Advisory Group LLC raised its holdings in CVS Health by 2.9% in the third quarter. HF Advisory Group LLC now owns 5,219 shares of the pharmacy operator’s stock worth $393,000 after purchasing an additional 145 shares in the last quarter. Finally, United Asset Strategies Inc. lifted its position in CVS Health by 1.8% during the third quarter. United Asset Strategies Inc. now owns 8,852 shares of the pharmacy operator’s stock valued at $667,000 after buying an additional 154 shares during the period. 80.66% of the stock is owned by hedge funds and other institutional investors.

CVS Health Stock Performance

Shares of CVS opened at $74.51 on Friday. CVS Health Corporation has a 12 month low of $53.36 and a 12 month high of $85.15. The business’s fifty day simple moving average is $78.90 and its two-hundred day simple moving average is $75.08. The company has a current ratio of 0.83, a quick ratio of 0.63 and a debt-to-equity ratio of 0.83. The company has a market cap of $94.59 billion, a price-to-earnings ratio of 196.09, a P/E/G ratio of 0.68 and a beta of 0.48.

CVS Health (NYSE:CVS) last announced its quarterly earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.36 by $0.24. CVS Health had a return on equity of 11.45% and a net margin of 0.12%.The firm had revenue of $102.87 billion for the quarter, compared to the consensus estimate of $98.85 billion. During the same period in the prior year, the company posted $1.09 earnings per share. The company’s quarterly revenue was up 7.8% on a year-over-year basis. Research analysts anticipate that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, February 2nd. Stockholders of record on Thursday, January 22nd will be issued a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.6%. The ex-dividend date of this dividend is Thursday, January 22nd. CVS Health’s dividend payout ratio (DPR) is presently 700.00%.

Wall Street Analyst Weigh In

Several research analysts recently issued reports on the stock. Weiss Ratings reiterated a “hold (c-)” rating on shares of CVS Health in a research note on Monday, December 29th. Mizuho raised their target price on shares of CVS Health from $88.00 to $95.00 and gave the company an “outperform” rating in a research note on Wednesday, December 10th. Wall Street Zen lowered shares of CVS Health from a “buy” rating to a “hold” rating in a report on Saturday, November 1st. Morgan Stanley upped their price target on CVS Health from $89.00 to $93.00 and gave the stock an “overweight” rating in a research note on Wednesday, December 10th. Finally, Evercore ISI lifted their price objective on CVS Health from $85.00 to $95.00 and gave the company an “outperform” rating in a research note on Thursday, October 30th. Nineteen analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. According to MarketBeat.com, CVS Health has an average rating of “Moderate Buy” and a consensus target price of $94.82.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.